NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Good morning. It’s budget day in the UK. Donald Trump directs his special envoy to meet with Vladimir Putin in Moscow. And the electric door Tesla made famous is now a danger in other cars. Listen to the day’s top stories.Read More